TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

Objective: to study the time course of changes in laboratory biomarkers in patients with rheumatoid arthritis (RA) 2, 4, and 8 weeks after the initiation of tocilizumab (TCZ) therapy. Subjects and methods. Forty-two RA patients receiving two intravenous infusions of TCZ (8 mg/kg each) at a 4-week in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: E N Aleksandrova, E Yu Panasyuk, A S Avdeyeva, A A Novikov, G V Lukina, M V Cherkasova, N V Klimova, E L Nasonov
Format: Artigo
Idioma:Russo
Publicat: IMA-PRESS LLC 2011-06-01
Col·lecció:Научно-практическая ревматология
Matèries:
rheumatoid arthritis, interleukin-6
interleukin-6 receptors
tocilizumab, erythrocyte sedimentation rate
c-reactive protein, igm/iga rheumatoid factor
anti-cyclic citrullinated peptide antibodies
anti-modified citrullinated vimentin antibodies
Accés en línia:https://rsp.mediar-press.net/rsp/article/view/705
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars